Alseres Pharmaceuticals, Inc.
OTC: ALSE0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- Other OTC
- Sector
- Healthcare
- Industry
- Biotechnology
- CEO
- Peter G. Savas
- Employees
- 3
- Headquarters
- Auburndale, United States
- IPO year
- 1994
- Market cap
- $398.3K
- Website
- https://www.alseres.com
Loading ALSE…
Loading profile data…Frequently asked questions about ALSE
What does Alseres Pharmaceuticals, Inc. (ALSE) do?
Alseres Pharmaceuticals, Inc. focuses on creating both diagnostic and therapeutic solutions, with a primary emphasis on ailments affecting the central nervous system. Their flagship experimental compound is Altropane, a molecular imaging agent developed for identifying and diagnosing Parkinson's disease and dementia. Founded in 1972, the company...
Where does ALSE trade?
Alseres Pharmaceuticals, Inc. (ALSE) trades on the Other OTC.
What sector is ALSE in?
Alseres Pharmaceuticals, Inc. (ALSE) operates in the Healthcare sector, specifically in the Biotechnology industry.
Who is the CEO of Alseres Pharmaceuticals, Inc.?
Peter G. Savas is the chief executive officer of Alseres Pharmaceuticals, Inc. (ALSE).
Where is Alseres Pharmaceuticals, Inc. headquartered?
Alseres Pharmaceuticals, Inc. is headquartered in United States.
Does ALSE pay a dividend?
Alseres Pharmaceuticals, Inc. (ALSE) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did ALSE go public?
Alseres Pharmaceuticals, Inc. (ALSE) completed its initial public offering in 1994.